SCHEMBL13085808

SCHEMBL13085808

c1ccc(-c2ccc(N(c3ccc(N(c4ccccc4)c4cccc5ccccc45)cc3)c3ccc4c(c3)C3(c5cc(N(c6ccc(-c7ccccc7)cc6)c6ccc(N(c7ccccc7)c7cccc8ccccc78)cc6)ccc5-4)c4ccccc4N(c4cccc5ccccc45)c4ccccc43)cc2)cc1

nearest known ligand 0.32

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 1/20 0.32
▸ ELANE P08246 1/20 0.32
▸ SIGMAR1 Q99720 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13085833 0.98 POLB (0.33) POLBELANE
SCHEMBL13085749 0.96 POLB (0.34) POLBELANE
SCHEMBL13085858 0.96 POLB (0.35) POLBELANESIGMAR1
SCHEMBL13085856 0.95 POLB (0.35) POLBELANE
SCHEMBL13085832 0.95 POLB (0.35) POLBELANESIGMAR1
SCHEMBL13085723 0.93 POLB (0.36) POLBELANE
SCHEMBL13085835 0.92 POLB (0.37) POLBELANE
SCHEMBL13085763 0.90 POLB (0.38) POLBELANE
SCHEMBL13085860 0.90 POLB (0.38) POLBELANE
SCHEMBL24646482 0.90 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7811682-B2 Compound and organic light emitting device using the same LG CHEM, LTD. (KR) 2010-10-12 — — US disclosed
US-7811682-B2 Compound and organic light emitting device using the same LG CHEM, LTD. (KR) 2010-10-12 — — US disclosed
US-20080303434-A1 Compound and Organic Light Emitting Device Using the Same LG CHEM, LTD. (KR) 2008-12-11 — — US disclosed
US-20080303434-A1 Compound and Organic Light Emitting Device Using the Same LG CHEM, LTD. (KR) 2008-12-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080303434-A1 Compound and Organic Light Emitting Device Using the Same PPOX, CRY1, CRY2 POLB 890/4885ELANE 2080/4885SIGMAR1 4092/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback